dc.contributor.author |
Debacq, Gabrielle |
|
dc.contributor.author |
Moyano, Luz M. |
|
dc.contributor.author |
García Lescano, Héctor Hugo |
|
dc.contributor.author |
Boumediene, Farid |
|
dc.contributor.author |
Marin, Benoit |
|
dc.contributor.author |
Ngoungou, Edgard B. |
|
dc.contributor.author |
Preux, Pierre-Marie |
|
dc.date.accessioned |
2019-01-25T16:03:21Z |
|
dc.date.available |
2019-01-25T16:03:21Z |
|
dc.date.issued |
2017 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/4771 |
|
dc.description.abstract |
BACKGROUND: We reviewed studies that analyzed cysticercosis (CC), neurocysticercosis (NCC) and epilepsy across Latin America, Asia and Sub-Saharan Africa, to estimate the odds ratio and etiologic fraction of epilepsy due to CC in tropical regions. METHODOLOGY: We conducted a systematic review of the literature on cysticercosis and epilepsy in the tropics, collecting data from case-control and cross-sectional studies. Exposure criteria for CC included one or more of the following: serum ELISA or EITB positivity, presence of subcutaneous cysts (both not verified and unverified by histology), histology consistent with calcified cysts, and brain CT scan consistent with NCC. A common odds-ratio was then estimated using meta-analysis. PRINCIPAL FINDINGS: 37 studies from 23 countries were included (n = 24,646 subjects, 14,934 with epilepsy and 9,712 without epilepsy). Of these, 29 were case-control (14 matched). The association between CC and epilepsy was significant in 19 scientific articles. Odds ratios ranged from 0.2 to 25.4 (a posteriori power 4.5-100%) and the common odds ratio was 2.7 (95% CI 2.1-3.6, p <0.001). Three subgroup analyses performed gave odds ratios as: 2.2 (EITB-based studies), 3.2 (CT-based studies), 1.9 (neurologist-confirmed epilepsy; door-to-door survey and at least one matched control per case). Etiologic fraction was estimated to be 63% in the exposed group among the population. SIGNIFICANCE: Despite differences in findings, this meta-analysis suggests that cysticercosis is a significant contributor to late-onset epilepsy in tropical regions around the world, and its impact may vary depending on transmission intensity. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Public Library of Science |
|
dc.relation.ispartofseries |
PLoS Neglected Tropical Diseases |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Africa South of the Sahara/epidemiology |
en_US |
dc.subject |
Asia/epidemiology |
en_US |
dc.subject |
Case-Control Studies |
en_US |
dc.subject |
Cross-Sectional Studies |
en_US |
dc.subject |
Cysticercosis/complications |
en_US |
dc.subject |
Epilepsy/epidemiology/etiology |
en_US |
dc.subject |
Humans |
en_US |
dc.subject |
Latin America/epidemiology |
en_US |
dc.title |
High Prevalence of Asymptomatic Neurocysticercosis in an Endemic Rural Community in Peru |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1371/journal.pntd.0005153 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.03.06 |
|
dc.relation.issn |
1935-2735 |
|